Tocilizumab for Treatment of Children and Young Adults With Severe Acute COVID-19: Experience at a Quaternary-care Children's Hospital.

Zheyi Teoh,Lara Danziger-Isakov,Joshua D Courter,Robert W Frenck,Michael S Grimley,Rebecca A Marsh,Grant C Paulsen,Christine L Phillips,Paul Spearman,Ranjit S Chima,Grant S Schulert

The Pediatric infectious disease journal（2023）

引用 4|浏览21

暂无评分

摘要

We describe the clinical characteristics and outcomes of 16 children and young adults with severe acute COVID-19 who were treated with tocilizumab. Patients who were discharged by day 28 were more likely to be treated with tocilizumab earlier in their COVID-19 illness and had lower ferritin and interleukin-6 levels compared with those who were not discharged by day 28.

查看译文

关键词

child,COVID-19,critical care,intensive care units,pediatrics,tocilizumab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要